Shaanxi Kanghui Pharmaceutical Co., Ltd.SSE: 603139

Announcement on Resolutions of the 4th General Meeting in 2025

· Issued by Shaanxi Kanghui Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

The meeting was held to discuss important matters, including changes to the company's business scope and amendments to the articles of association. All proposed resolutions were approved by the shareholders present at the meeting, with no dissenting votes recorded. The filing confirms that the meeting was conducted in accordance with relevant laws and regulations, ensuring the validity of the proceedings.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix

Earlier from Shaanxi Kanghui Pharmaceutical

Later from Shaanxi Kanghui Pharmaceutical

All Shaanxi Kanghui Pharmaceutical news releases